Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy
- Author
- ETIEBET, Mary-Ann A1 ; SHEPHERD, James1 ; EYZAGUIRRE, Lindsay M1 ; BLATTNER, William A1 ; NOWAK, Rebecca G1 ; CHARURAT, Man1 ; CHANG, Harry1 ; AJAYI, Samuel3 ; ELEGBA, Olufunmilayo4 ; NDEMBI, Nicaise2 ; ABIMIKU, Alashle1 ; CARR, Jean K1
[1] Institute of Human Virology, University of Maryland School of Medicine, Maryland, United States
[2] Institute of Human Virology Nigeria, Abuja, Nigeria
[3] University of Abuja Teaching Hospital, Gwagwalada, United States
[4] National Hospital Abuja, Abuja, Federal Capital Territory, Nigeria - Source
AIDS (London). 2013, Vol 27, Num 4, pp 553-561, 9 p ; ref : 54 ref
- ISSN
- 0269-9370
- Scientific domain
- Immunology, immunopathology, allergology; Microbiology, infectious diseases
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HIV-1 drug resistance non-B subtype resource-limited settings second line tenofovir disoproxil fumarate thymidine analog mutations
- Keyword (fr)
- Antirétroviral Antiviral Chimiothérapie Mutation Résistance traitement SIDA Soustype Thymidine Typage Ténofovir Virus HIV1 Analogue de nucléoside Analogue de nucléotide Enzyme Exploration microbiologique Immunodéficit Immunopathologie Infection Inhibiteur enzyme Inhibiteur reverse transcriptase Lentivirus Nucleotidyltransferases Nucléotide acyclique Phosphonate organique Purine nucléotide Pyrimidine nucléoside RNA-directed DNA polymerase Retroviridae Traitement Transferases Virose Virus immunodéficience humaine Virus
- Keyword (en)
- Antiretroviral agent Antiviral Chemotherapy Mutation Treatment resistance AIDS Subtype Thymidine Typing Tenofovir HIV-1 virus Nucleoside analog Nucleotide analog Enzyme Microbiological investigation Immune deficiency Immunopathology Infection Enzyme inhibitor Reverse transcriptase inhibitor Lentivirus Nucleotidyltransferases Acyclic nucleotide Organic phosphonate Purine nucleotide Pyrimidine nucleoside RNA-directed DNA polymerase Retroviridae Treatment Transferases Viral disease Human immunodeficiency virus Virus
- Keyword (es)
- Antiretroviral Antiviral Quimioterapia Mutación Resistencia tratamiento SIDA Subtipo Timidina Tipificación Tenofovir HIV-1 virus Análogo nucleósido Análogo nucléotido Enzima Análisis microbiológico Inmunodeficiencia Inmunopatología Infección Inhibidor enzima Inhibitor reverse transcriptase Lentivirus Nucleotidyltransferases Nucleótido acíclico Fosfonato orgánico Purina nucleótido Pirimidina nucleósido RNA-directed DNA polymerase Retroviridae Tratamiento Transferases Virosis Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies
- Discipline
- Immunopathology Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27077563
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/QAD.0b013e32835b0f59 
https://dx.doi.org/10.1097/QAD.0b013e32835b0f59
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"553\";s:8:\"\u0000*\u0000epage\";s:3:\"561\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ETIEBET\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Mary-Ann A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"SHEPHERD, James\";i:1;s:21:\"EYZAGUIRRE, Lindsay M\";i:2;s:19:\"BLATTNER, William A\";i:3;s:16:\"NOWAK, Rebecca G\";i:4;s:13:\"CHARURAT, Man\";i:5;s:12:\"CHANG, Harry\";i:6;s:13:\"AJAYI, Samuel\";i:7;s:20:\"ELEGBA, Olufunmilayo\";i:8;s:15:\"NDEMBI, Nicaise\";i:9;s:16:\"ABIMIKU, Alashle\";i:10;s:12:\"CARR, Jean K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"553\";s:8:\"\u0000*\u0000epage\";s:3:\"561\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ETIEBET\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Mary-Ann A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"SHEPHERD, James\";i:1;s:21:\"EYZAGUIRRE, Lindsay M\";i:2;s:19:\"BLATTNER, William A\";i:3;s:16:\"NOWAK, Rebecca G\";i:4;s:13:\"CHARURAT, Man\";i:5;s:12:\"CHANG, Harry\";i:6;s:13:\"AJAYI, Samuel\";i:7;s:20:\"ELEGBA, Olufunmilayo\";i:8;s:15:\"NDEMBI, Nicaise\";i:9;s:16:\"ABIMIKU, Alashle\";i:10;s:12:\"CARR, Jean K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"553\";s:8:\"\u0000*\u0000epage\";s:3:\"561\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ETIEBET\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Mary-Ann A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"SHEPHERD, James\";i:1;s:21:\"EYZAGUIRRE, Lindsay M\";i:2;s:19:\"BLATTNER, William A\";i:3;s:16:\"NOWAK, Rebecca G\";i:4;s:13:\"CHARURAT, Man\";i:5;s:12:\"CHANG, Harry\";i:6;s:13:\"AJAYI, Samuel\";i:7;s:20:\"ELEGBA, Olufunmilayo\";i:8;s:15:\"NDEMBI, Nicaise\";i:9;s:16:\"ABIMIKU, Alashle\";i:10;s:12:\"CARR, Jean K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"553\";s:8:\"\u0000*\u0000epage\";s:3:\"561\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ETIEBET\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Mary-Ann A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"SHEPHERD, James\";i:1;s:21:\"EYZAGUIRRE, Lindsay M\";i:2;s:19:\"BLATTNER, William A\";i:3;s:16:\"NOWAK, Rebecca G\";i:4;s:13:\"CHARURAT, Man\";i:5;s:12:\"CHANG, Harry\";i:6;s:13:\"AJAYI, Samuel\";i:7;s:20:\"ELEGBA, Olufunmilayo\";i:8;s:15:\"NDEMBI, Nicaise\";i:9;s:16:\"ABIMIKU, Alashle\";i:10;s:12:\"CARR, Jean K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e32835b0f59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"553\";s:8:\"\u0000*\u0000epage\";s:3:\"561\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"ETIEBET\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Mary-Ann A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"SHEPHERD, James\";i:1;s:21:\"EYZAGUIRRE, Lindsay M\";i:2;s:19:\"BLATTNER, William A\";i:3;s:16:\"NOWAK, Rebecca G\";i:4;s:13:\"CHARURAT, Man\";i:5;s:12:\"CHANG, Harry\";i:6;s:13:\"AJAYI, Samuel\";i:7;s:20:\"ELEGBA, Olufunmilayo\";i:8;s:15:\"NDEMBI, Nicaise\";i:9;s:16:\"ABIMIKU, Alashle\";i:10;s:12:\"CARR, Jean K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
